Efficacy and Safety of UI05MSP015CT in Functional Dyspepsia: A Randomized, Controlled Trial

BACKGROUND/AIMS: To evaluate the efficacy and safety of a controlled release, once-daily formulation of mosapride (UI05MSP015CT) in patients with functional dyspepsia (FD). METHODS: Patients with FD were randomly assigned (1:1) to receive either UI05MSP015CT (15 mg once a day, study group) or mosapr...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Hyuk, Lee, Dong Ho, Lee, Yong-Hyun, Jeong, Ju-Cheol, Lee, Soo Teik, Choi, Myung-Gyu, Jeon, Seong Woo, Shim, Ki-Nam, Baik, Gwang Ho, Kim, Jae Gyu, Moon, Jeong Seop, Sung, In-Kyung, Lee, Sang Kil, Rhee, Poong-Lyul, Jung, Hwoon-Yong, Lee, Bong Eun, Kim, Hyun Soo, Kim, Sang Gyun, Lee, Kee Myung, Seong, Jae Kyu, Jang, Jin Seok, Park, Jong-Jae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143453/
https://www.ncbi.nlm.nih.gov/pubmed/29938452
http://dx.doi.org/10.5009/gnl17416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143453/
https://www.ncbi.nlm.nih.gov/pubmed/29938452
http://dx.doi.org/10.5009/gnl17416

Ejemplares similares